Fernando Andreu

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

Part of Sysmex Corp., Sysmex Inostics GmbH is a German company that develops advanced genetic testing technologies. The company is based in Hamburg, Germany. The CEOs are Bhuwnesh Agrawal, Seido Biwa, Mamoru Kubota. The company was founded by Luis Diaz. Sysmex Inostics was acquired by Sysmex Corp. from Indivumed GmbH on September 25, 2013.

Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany.